{
    "applicationNumber": "BR 11 2021 013715-7",
    "filingDate": "14/01/2020",
    "grantDate": null,
    "title": "PROTE\u00cdNA DE FUS\u00c3O, MOL\u00c9CULA DE \u00c1CIDO NUCLEICO, M\u00c9TODOS PARA MODULAR A CLIVAGEM, A POLIADENILA\u00c7\u00c3O, OU AMBAS, DE UM TRANSCRITO DE RNA, PARA VISUALIZAR RNA NUCLEAR E PARA DIMINUIR O N\u00daMERO DE RNA NUCLEAR OU PARA CLIVAR RNA NUCLEAR, E, USO DA PROTE\u00cdNA DE FUS\u00c3O",
    "nationalPhaseDate": [
        "12/07/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2020/013577",
        "pctDate": "14/01/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/791,971",
            "priorityDate": "14/01/2019"
        },
        {
            "countryCode": "US",
            "priorityNumber": "62/877,415",
            "priorityDate": "23/07/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2637"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2646"
        }
    ],
    "inventors": [
        "DOUGLAS MATTHEW ANDERSON"
    ],
    "holders": [
        207610
    ],
    "ipcCodes": [
        "C12N 15/62",
        "C12N 9/22"
    ]
}